Ad
Tuesday, 7 February 2017
FTC sues Shire ViroPharma for fighting generic entry of Vancocin
WASHINGTON (Reuters) - The U.S. Federal Trade Commission filed a complaint against Shire ViroPharma on Tuesday, accusing it of abusing government processes in order to fend off generic competition to its antibiotic Vancocin HCI, the agency said in a statement.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment